Consulting services to meet GxP CSV requirements
for Pharmaceuticals and Medical devices
Hiro Pharma Consulting® Co., Ltd. will celebrate its fourth anniversary since incorporation on November 1, 2025. In addition, on July 1, 2025, we will celebrate our sixth anniversary since our founding as a sole proprietorship. We owe this entirely to your support and patronage. We would like to express our sincere gratitude.
![日本語訳版）FDA 「医薬品および生物学的製剤の規制判断を支援する人工知能（AI）の使用に関する考察」 （ドラフト）： FDA [Considerations for the Use of Artificial Intelligence to Support Regulatory Decision/Making for Drug and Biological Products. Draft Guidance for Industry and Other Interested Parties]](https://hiropharmaconsulting.com/wp-content/uploads/2025/05/FDA-AI_Guidance_Draft_Japanese.png)
![India 「インド規制当局：中央医薬品基準管理機構（CDSCO）」[Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products Version: 2.0]](https://hiropharmaconsulting.com/wp-content/uploads/2025/04/Pharmacovigilance-Guidance-Document_LOGO.png){kind=logo}
